SCHEMBL4907232

SCHEMBL4907232

O=C(O)NOC(=O)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.76
KMT2A Q03164 5/20 0.76
MAPT P10636 4/20 0.76
POLB P06746 2/20 0.76
TSHR P16473 5/20 0.60
LMNA P02545 2/20 0.58
F2 P00734 1/20 0.58
PKM P14618 1/20 0.50
CASP3 P42574 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
TDP1 Q9NUW8 5/20 0.48
TP53 P04637 1/20 0.48
HSD17B10 Q99714 3/20 0.48
CYP3A4 P08684 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
PARP1 P09874 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809526 0.86 ALDH1A1 (1.00) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL29102460 0.86 ALDH1A1 (0.70) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL6269137 0.86 ALDH1A1 (0.70) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL27509048 0.85 KMT2A (0.68) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL158309 0.85 KMT2A (0.68) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL11146599 0.85 ALDH1A1 (0.96) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL1107202 0.85 ALDH1A1 (0.68) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL3035584 0.84 ALDH1A1 (0.67) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL9150262 0.83 ALDH1A1 (0.66) ALDH1A1KMT2AMAPTPOLBTSHR
SCHEMBL7645360 0.83 ALDH1A1 (0.66) ALDH1A1KMT2AMAPTPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509941-A2 N-ACYLATED HYDROXYLAMINE DERIVATIVES AND O-ACYLATED HYDROXYLAMINE DERIVATIVES The Johns Hopkins University (US) 2012-10-17 EP disclosed
US-20080183007-A1 Process For the Preparation of Alkyl Phosphinic Acids ASTRAZENECA AB (SE) 2008-07-31 US disclosed
EP-1799695-A1 NEW PROCESS FOR THE PREPARATION OF ALKYL PHOSPHINIC ACIDS AstraZeneca AB (SE) 2007-06-27 EP disclosed
WO-2006038870-A1 NEW PROCESS FOR THE PREPARATION OF ALKYL PHOSPHINIC ACIDS ASTRAZENECA AB (SE) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080183007-A1 Process For the Preparation of Alkyl Phosphinic Acids PPIP5K2, AGPS, ITPA ALDH1A1 2377/4885KMT2A 1758/4885MAPT 4798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.